![Max Jonson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Max Jonson
Direttore Finanziario/CFO presso
BURE EQUITY AB
Patrimonio netto: 380 316 $ in data 31/05/2026
Profilo
Max Jonson is currently Director at BioLamina AB, Bure Growth AB, and Skanditek AB. Mr. Jonson is Chief Financial Officer at Bure Equity AB and Bure Equity since 2013.
Former roles include Director at Celemiab Group AB (2014–2016), Dipylon Medical AB (2016–2017), Atle Investment Management AB, and Celemi International AB (2016–2018).
Mr. Jonson was Associate Director-Corporate Finance at SEB Group (Sweden) from 1996 to 2003.
Other former positions include Chief Financial Officer at Orasolv AB (2011–2012), Stockholm School of Economics Ifl (2012–2013), Sse Executive Education (2012–2013), and ACQ Bure AB. Mr. Jonson was Finance Manager at Dpnova AB (2011–2013) and held a Chief Financial Officer role at Yubico AB. Education includes an MBA from The University of Chicago and undergraduate studies at New York University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
BURE EQUITY AB 0,02% | 01/06/2026 | 12.760 ( 0,02% ) | 380 316 $ | 31/05/2026 |
Posizioni attive di Max Jonson
| Società | Posizione | Inizio |
|---|---|---|
| BURE EQUITY AB | Direttore Finanziario/CFO | 01/10/2013 |
Skanditek AB | Direttore/Membro del Consiglio | - |
BioLamina AB
 BioLamina AB BiotechnologyHealth Technology Develops, manufactures, and markets cell culture reagents intended for culturing of primary cells | Direttore/Membro del Consiglio | - |
Bure Growth AB
 Bure Growth AB Financial ConglomeratesFinance Provides investment services | Direttore/Membro del Consiglio | - |
Bure Equity (Private Equity)
 Bure Equity (Private Equity) Investment ManagersFinance Bure Equity invests in middle market companies located in Sweden. The firm targets companies operating across a broad range of sectors and industries. It provides financing for buyout transactions. | Direttore Finanziario/CFO | 01/09/2013 |
Precedenti posizioni note di Max Jonson
| Società | Posizione | Fine |
|---|---|---|
Celemi International AB | Direttore/Membro del Consiglio | 01/01/2018 |
Dipylon Medical AB
 Dipylon Medical AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products and manufactures medical instruments | Direttore/Membro del Consiglio | 01/01/2017 |
Celemiab Group AB
 Celemiab Group AB Miscellaneous Commercial ServicesCommercial Services Provides consultancy and training services | Direttore/Membro del Consiglio | 01/01/2016 |
Sse Executive Education | Direttore Finanziario/CFO | 01/01/2013 |
| ░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Max Jonson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
12
Relazioni di 1° grado
18
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 18 |
|---|---|
Bure Equity AB
 Bure Equity AB Financial ConglomeratesFinance Provides equity and investment services | Finance |
Orasolv AB
 Orasolv AB Medical/Nursing ServicesHealth Services Engages in the provision of dental care and acquisition of companies in the dental industry | Health Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bure Equity (Private Equity)
Bure Equity (Private Equity) Investment ManagersFinance Bure Equity invests in middle market companies located in Sweden. The firm targets companies operating across a broad range of sectors and industries. It provides financing for buyout transactions. | Finance |
Celemiab Group AB
Celemiab Group AB Miscellaneous Commercial ServicesCommercial Services Provides consultancy and training services | Commercial Services |
Dpnova AB
 Dpnova AB Medical/Nursing ServicesHealth Services Develops and manufactures dental implants | Health Services |
Dipylon Medical AB
Dipylon Medical AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products and manufactures medical instruments | Health Technology |
BioLamina AB
BioLamina AB BiotechnologyHealth Technology Develops, manufactures, and markets cell culture reagents intended for culturing of primary cells | Health Technology |
Stockholm School of Economics Ifl
 Stockholm School of Economics Ifl Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atle Investment Management AB | |
Bure Growth AB
Bure Growth AB Financial ConglomeratesFinance Provides investment services | Finance |
Celemi International AB | |
SEB Group (Sweden) | |
ACQ Bure AB
 ACQ Bure AB Financial ConglomeratesFinance Operates as a special purpose acquisition company | Finance |
Skanditek AB | |
Sse Executive Education | |
Yubico AB
 Yubico AB Electronics DistributorsDistribution Services Wholesales computers and software | Distribution Services |
